XenoPort Inc (XNPT)

7.07
0.05 0.71
Prev Close 7.02
Open 7.04
Day Low/High 7.02 / 7.07
52 Wk Low/High 3.35 / 7.86
Volume 2.62M
Avg Volume 1.64M
Exchange
Shares Outstanding 63.53M
Market Cap 449.13M
EPS -1.30
Div & Yield N.A. (N.A)
XenoPort Appoints Ernest Mario, Ph.D., To Board Of Directors

XenoPort Appoints Ernest Mario, Ph.D., To Board Of Directors

XenoPort, Inc. (Nasdaq:XNPT) announced today the appointment of Ernest Mario, Ph.

5 Stocks Under $10 Soaring Higher

5 Stocks Under $10 Soaring Higher

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

GSK And XenoPort Receive FDA Approval For Horizant® For Postherpetic Neuralgia

GSK And XenoPort Receive FDA Approval For Horizant® For Postherpetic Neuralgia

GlaxoSmithKline plc (GSK) and XenoPort, Inc. (Nasdaq:XNPT) announced today that the United States (US) Food and Drug Administration (FDA) has approved Horizant ® (gabapentin enacarbil) Extended-Release Tablets for...

XenoPort Announces Key Management Promotions

XenoPort Announces Key Management Promotions

XenoPort, Inc. (Nasdaq:XNPT) announced today that it has promoted Vincent J.

XenoPort Announces New Employment Inducement Award

XenoPort Announces New Employment Inducement Award

XenoPort, Inc. (Nasdaq:XNPT) reported today that an equity award was made to a new employee subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan.

XenoPort Submits Investigational New Drug Application For XP23829 As A Potential Treatment Of RRMS

XenoPort Submits Investigational New Drug Application For XP23829 As A Potential Treatment Of RRMS

XenoPort, Inc. (Nasdaq:XNPT) announced today that it has submitted an Investigational New Drug (IND) application to the U.

XenoPort Reports First Quarter Financial Results

XenoPort Reports First Quarter Financial Results

XenoPort, Inc. (Nasdaq: XNPT) announced today its financial results for the first quarter ended March 31, 2012.

XenoPort To Present At The Deutsche Bank Annual Health Care Conference

XenoPort To Present At The Deutsche Bank Annual Health Care Conference

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Deutsche Bank 37 th Annual Health Care Conference.

XenoPort To Present At The Cowen And Company 32nd Annual Health Care Conference

XenoPort To Present At The Cowen And Company 32nd Annual Health Care Conference

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Cowen and Company 32nd Annual Health Care Conference.

XenoPort To Present At The RBC Capital Markets' Healthcare Conference

XenoPort To Present At The RBC Capital Markets' Healthcare Conference

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the RBC Capital Markets' Healthcare Conference.

XenoPort Reports Fourth Quarter And Year-End 2011 Financial Results

XenoPort Reports Fourth Quarter And Year-End 2011 Financial Results

XenoPort, Inc. (Nasdaq:XNPT) announced today its financial results for the fourth quarter and year ended December 31, 2011.

XenoPort To Present At The Leerink Swann Global Healthcare Conference

XenoPort To Present At The Leerink Swann Global Healthcare Conference

XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Leerink Swann Global Healthcare Conference.

XenoPort To Release Fourth Quarter And Year-End Financial Results On February 14, 2012

XenoPort To Release Fourth Quarter And Year-End Financial Results On February 14, 2012

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its fourth quarter financial results on February 14, 2012 at approximately 4:30 p.

Astellas And XenoPort Announce Approval Of Regnite® Tablets For Restless Legs Syndrome In Japan

Astellas And XenoPort Announce Approval Of Regnite® Tablets For Restless Legs Syndrome In Japan

Astellas Pharma Inc. (Tokyo:4503) and XenoPort, Inc.

XenoPort To Present At The 30th Annual J.P. Morgan Healthcare Conference

XenoPort To Present At The 30th Annual J.P. Morgan Healthcare Conference

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 30 th Annual J.

XenoPort Announces New Employment Inducement Award

XenoPort Announces New Employment Inducement Award

XenoPort, Inc. (Nasdaq:XNPT) reported today that an equity award was made to a new employee subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan.

XenoPort Announces XP21279 Phase 2 Clinical Trial Results In Patients With Advanced Parkinson’s Disease

XenoPort Announces XP21279 Phase 2 Clinical Trial Results In Patients With Advanced Parkinson’s Disease

XenoPort, Inc. (Nasdaq:XNPT) announced today preliminary top-line results of a Phase 2, randomized, crossover clinical trial that compared optimized treatment with either Sinemet (immediate-release levodopa/carbidopa)...

XenoPort To Present At The 23rd Annual Piper Jaffray Health Care Conference

XenoPort To Present At The 23rd Annual Piper Jaffray Health Care Conference

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 23rd Annual Piper Jaffray Health Care Conference.

XenoPort Reports Third Quarter Financial Results

XenoPort Reports Third Quarter Financial Results

XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the third quarter and nine months ended September 30, 2011.

XenoPort To Release Third Quarter Financial Results On November 2, 2011

XenoPort To Release Third Quarter Financial Results On November 2, 2011

XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its third quarter financial results on November 2, 2011 at approximately 4:30 p.

XenoPort Announces New Employment Inducement Awards

XenoPort Announces New Employment Inducement Awards

XenoPort, Inc. (Nasdaq: XNPT) reported today that equity awards were made to three new employees subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan.

XenoPort To Present At Upcoming Healthcare Conferences

XenoPort To Present At Upcoming Healthcare Conferences

XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentations at the Morgan Stanley Global Healthcare Conference and the UBS Global Life Sciences Conference.

Regulatory Update: GSK And XenoPort Submit Supplemental New Drug Application To FDA For Horizant™ In Postherpetic Neuralgia

Regulatory Update: GSK And XenoPort Submit Supplemental New Drug Application To FDA For Horizant™ In Postherpetic Neuralgia

GlaxoSmithKline (NYSE:GSK)(LSE:GSK) and XenoPort, Inc. (Nasdaq: XNPT) announced today that a supplemental New Drug Application (sNDA) has been submitted to the U.

XenoPort To Present At The Wedbush Life Sciences Conference

XenoPort To Present At The Wedbush Life Sciences Conference

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2011 Wedbush Life Sciences: Management Access Conference.

XenoPort Reports Second Quarter Financial Results

XenoPort Reports Second Quarter Financial Results

XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the second quarter and six months ended June 30, 2011.

XenoPort To Release Second Quarter Financial Results On August 3, 2011

XenoPort To Release Second Quarter Financial Results On August 3, 2011

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its second quarter financial results on August 3, 2011 at approximately 4:30 p.

XenoPort Announces New Employment Inducement Award

XenoPort Announces New Employment Inducement Award

XenoPort, Inc. (Nasdaq:XNPT) reported today that an equity award was made to a new employee subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan.

XenoPort Reports First Quarter Financial Results

XenoPort Reports First Quarter Financial Results

XenoPort, Inc. (Nasdaq: XNPT) announced today its financial results for the first quarter ended March 31, 2011.

XenoPort To Release First Quarter Financial Results On May 4, 2011

XenoPort To Release First Quarter Financial Results On May 4, 2011

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its first quarter financial results on May 4, 2011 at approximately 4:30 p.